The Senate Finance Committee is widening a probe into tax-exempt organizations — including patient advocacy groups and medical associations — that have financial ties with opioid makers in a bid to shed light on the extent to which these relationships affected the ongoing opioid crisis afflicting the U.S.

Last Friday, letters were sent by Sen. Chuck Grassley (R-Iowa), who heads the committee, and Sen. Ron Wyden (D-Ore.), the minority leader, to 10 organizations, including the Federation of State Medical Boards, which supports physician licensing and regulation; The Joint Commission, which accredits health care organizations; and such groups as the American Chronic Pain Association and the American Society of Pain Educators.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy